期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Expert consensus on odontogenic maxillary sinusitis multi-disciplinary treatment 被引量:2
1
作者 Jiang Lin chengshuo wang +18 位作者 Xiangdong wang Faming Chen Wei Zhang Hongchen Sun Fuhua Yan Yaping Pan Dongdong Zhu Qintai Yang Shaohua Ge Yao Sun Kuiji wang Yuan Zhang Mu Xian Ming Zheng Anchun Mo Xin Xu Hanguo wang Xuedong Zhou Luo Zhang 《International Journal of Oral Science》 SCIE CAS CSCD 2024年第1期1-14,共14页
Odontogenic maxillary sinusitis (OMS) is a subtype of maxillary sinusitis (MS). It is actually inflammation of the maxillary sinus that secondary to adjacent infectious maxillary dental lesion. Due to the lack of uniq... Odontogenic maxillary sinusitis (OMS) is a subtype of maxillary sinusitis (MS). It is actually inflammation of the maxillary sinus that secondary to adjacent infectious maxillary dental lesion. Due to the lack of unique clinical features, OMS is difficult to distinguish from other types of rhinosinusitis. Besides, the characteristic infectious pathogeny of OMS makes it is resistant to conventional therapies of rhinosinusitis. Its current diagnosis and treatment are thus facing great difficulties. The multi-disciplinary cooperation between otolaryngologists and dentists is absolutely urgent to settle these questions and to acquire standardized diagnostic and treatment regimen for OMS. However, this disease has actually received little attention and has been underrepresented by relatively low publication volume and quality. Based on systematically reviewed literature and practical experiences of expert members, our consensus focuses on characteristics, symptoms, classification and diagnosis of OMS, and further put forward multidisciplinary treatment decisions for OMS, as well as the common treatment complications and relative managements. This consensus aims to increase attention to OMS, and optimize the clinical diagnosis and decision-making of OMS, which finally provides evidence-based options for OMS clinical management. 展开更多
关键词 DIAGNOSIS SINUSITIS MAXILLARY
在线阅读 下载PDF
Decreased FEF_(50) as an indicator of comorbid asthma and persistent airflow limitation in patients with chronic rhinosinusitis with nasal polyps:A cross-sectional study
2
作者 Xuechen wang Fangyuan Li +5 位作者 chengshuo wang Kai Huang Shen Shen Ming wang Jianmin Jin Luo Zhang 《Chinese Medical Journal》 SCIE CAS CSCD 2024年第3期353-355,共3页
To the Editor:While 20–60%of patients with chronic rhinosinusitis with nasal polyps(CRSwNP)have comorbid asthma(known as refractory asthma),asthma is undiagnosed in 25–48%of CRSwNP patients with comorbid asthma._([1... To the Editor:While 20–60%of patients with chronic rhinosinusitis with nasal polyps(CRSwNP)have comorbid asthma(known as refractory asthma),asthma is undiagnosed in 25–48%of CRSwNP patients with comorbid asthma._([1])Moreover,the prevalence of persistent airflow limitation(PAL)is high in CRSwNP patients with comorbid asthma.However,the factors indicating comorbid asthma in patients with CRSwNP and reflecting PAL in those with comorbid asthma have not been fully elucidated.Small airway dysfunction(SAD)has been found in CRSwNP patients,even in the absence of asthma;and the severity of SAD in patients with comorbid asthma is correlated with the duration of asthma history._([2])This study therefore aimed to evaluate the clinical characteristics,especially small airway parameters as indicators of comorbid asthma in patients with CRSwNP and of PAL in CRSwNP patients with comorbid asthma.Besides,in order to identify the characteristics of CRSwNP patients with asthma,we also compared the prevalence of SAD and PAL between asthma patients with or without CRSwNP. 展开更多
关键词 ASTHMA PATIENTS MORBID
原文传递
生物制剂治疗慢性鼻窦炎伴鼻息肉 被引量:6
3
作者 王成硕 张罗 《中华耳鼻咽喉头颈外科杂志》 CSCD 北大核心 2023年第3期193-199,共7页
慢性鼻窦炎伴鼻息肉(CRSwNP)约占慢性鼻窦炎(CRS)的1/3,是临床常见的鼻窦黏膜慢性炎性疾病。部分CRSwNP患者临床症状严重,经药物和手术治疗后,症状仍持续存在或复发,是临床难以控制的难治性患者。近年来问世的生物制剂治疗提供了新的治... 慢性鼻窦炎伴鼻息肉(CRSwNP)约占慢性鼻窦炎(CRS)的1/3,是临床常见的鼻窦黏膜慢性炎性疾病。部分CRSwNP患者临床症状严重,经药物和手术治疗后,症状仍持续存在或复发,是临床难以控制的难治性患者。近年来问世的生物制剂治疗提供了新的治疗方法。本文在分析近期发表的网状Meta分析研究和系统性综述的临床研究数据基础上,重点介绍生物制剂治疗CRSwNP的适应证、用法、疗效评价、安全性和治疗花费情况。建议在把握好临床应用关键环节的前提下稳妥应用生物制剂,积极探索治疗难治性CRSwNP的新途径。 展开更多
关键词 慢性鼻窦炎 生物制剂 系统性综述 慢性炎性疾病 CRS 临床症状 临床应用 新的治疗方法
原文传递
过敏性鼻炎高度流行,新疗法是否有助解决治愈?
4
作者 王明 王成硕 +1 位作者 Cezmi A.Akdis 张罗 《Science Bulletin》 SCIE EI CAS CSCD 2023年第24期3094-3097,共4页
Allergic rhinitis(AR)is caused by a hyperresponse of the immune system to allergens and results in inflammatory disorders of the nasal mucosa,leading to symptoms,such as sneezing,nasal discharge,itching,and congestion... Allergic rhinitis(AR)is caused by a hyperresponse of the immune system to allergens and results in inflammatory disorders of the nasal mucosa,leading to symptoms,such as sneezing,nasal discharge,itching,and congestion.AR symptoms have been reported in China since ancient times. 展开更多
关键词 过敏性鼻炎 NASAL RHINITIS
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部